1. Home
  2. KALV vs NBN Comparison

KALV vs NBN Comparison

Compare KALV & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$19.95

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Northeast Bank

NBN

Northeast Bank

HOLD

Current Price

$124.64

Market Cap

933.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
NBN
Founded
N/A
1872
Country
United States
United States
Employees
N/A
234
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
933.4M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
KALV
NBN
Price
$19.95
$124.64
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$32.60
$117.50
AVG Volume (30 Days)
1.1M
103.5K
Earning Date
05-09-2026
04-28-2026
Dividend Yield
N/A
0.03%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
N/A
Revenue This Year
$187.19
$13.77
Revenue Next Year
$54.93
$18.72
P/E Ratio
N/A
$11.29
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$79.05
52 Week High
$21.31
$126.26

Technical Indicators

Market Signals
Indicator
KALV
NBN
Relative Strength Index (RSI) 62.29 76.54
Support Level $14.66 $104.40
Resistance Level $21.31 $126.26
Average True Range (ATR) 1.35 3.42
MACD 0.14 1.75
Stochastic Oscillator 75.14 99.79

Price Performance

Historical Comparison
KALV
NBN

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.

Share on Social Networks: